Literature DB >> 927466

Effect of low-dose propantheline on food-stimulated gastric acid secretion: comparison with an "optimal effective dose" and interaction with cimetidine.

M Feldman, C T Richardson, W L Peterson, J H Walsh, J S Fordtran.   

Abstract

We evaluated the widely held notion that anticholinergic drugs must be used in near toxic doses to inhibit gastric acid secretion effectively. Nine patients with duodenal ulcer were studied after a low dose (15 mg) and after a near toxic dose (averaging 48 mg) of the anticholinergic, propantheline. Mean (+/- S.E.) inhibition of food-stimulated acid secretion was identical with the two doses of propantheline: 29 +/- 10 and 29 +/- 11 per cent, respectively. In addition, when 15 mg of propantheline was combined with the histamine H2-receptor antagonist, cimetidine, acid secretion was suppressed to a greater degree than with either drug alone. A low dose of propantheline is as effective as a near toxic dose in suppressing food-stimulated acid secretion and augments the inhibitory effect of cimetidine.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 927466     DOI: 10.1056/NEJM197712292972603

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  15 in total

1.  Effect of placebo on meal-stimulated gastric acid secretion and serum gastrin concentration. Studies in healthy volunteers and duodenal ulcer patients.

Authors:  M Feldman; C T Richardson
Journal:  Dig Dis Sci       Date:  1988-02       Impact factor: 3.199

2.  The effect of 15(R)-15-methyl prostaglandin E2 on meal-stimulated gastric acid secretion, serum gastrin, and pancreatic polypeptide in duodenal ulcer patients.

Authors:  W Peterson; M Feldman; I Taylor; M Bremer
Journal:  Dig Dis Sci       Date:  1979-05       Impact factor: 3.199

Review 3.  Current therapy in peptic ulcer.

Authors:  I N Marks
Journal:  Drugs       Date:  1980-10       Impact factor: 9.546

4.  Resistant duodenal ulcer: when, why and what to do?

Authors:  R P Walt; T K Daneshmend
Journal:  Postgrad Med J       Date:  1988-05       Impact factor: 2.401

5.  Effect of H2-receptor antagonists, cimetidine and YM-11170, on serum gastrin levels in lumen-perfused rats.

Authors:  K Ohe; M Nakamura; T Fujiwara; H Matsumoto; M Kohchi; A Miyoshi
Journal:  Dig Dis Sci       Date:  1983-11       Impact factor: 3.199

6.  Cimetidine or propantheline combined with antacid therapy for short-term treatment of duodenal ulcer.

Authors:  H O Adami; O Björklund; L K Enander; S Gustavsson; L Lööf; A Nordahl; A Rosén
Journal:  Dig Dis Sci       Date:  1982-05       Impact factor: 3.199

7.  Anti-ulcer therapy. Past to present.

Authors:  A Bettarello
Journal:  Dig Dis Sci       Date:  1985-11       Impact factor: 3.199

8.  Effect of isopropamide on response to oral cimetidine in patients with Zollinger--Ellison syndrome.

Authors:  D M McCarthy; P E Hyman
Journal:  Dig Dis Sci       Date:  1982-04       Impact factor: 3.199

9.  Complete inhibition of food-stimulated gastric acid secretion by combined application of pirenzepine and ranitidine.

Authors:  W Londong; V Londong; C Ruthe; P Weizert
Journal:  Gut       Date:  1981-07       Impact factor: 23.059

10.  Effect of antral instillation of bile salts on fasting serum gastrin levels.

Authors:  J S Levine; J E Coonan; F Kern
Journal:  Dig Dis Sci       Date:  1980-06       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.